Browse the evidence

Low-sodium diets are significantly associated with hypertension and dyslipidaemia management, but not significantly associated with diabetes in this population.

If you have high blood pressure or high cholesterol, reducing your sodium intake to under 2000mg per day is associated with better health outcomes. However, this specific restriction may not help manage diabetes.

Ketogenic and low-carbohydrate diets improve glycemic control and can induce remission, primarily through weight loss, though some benefits may occur independently of weight loss via reduced glycemic load.

A ketogenic or low-carbohydrate diet can significantly lower blood sugar and HbA1c, sometimes even without major weight loss. This is achieved by drastically reducing carbs and eating healthy fats. While weight loss often accompanies this and aids remission, the direct reduction in glycemic load is also beneficial. Monitor your lipid levels and ensure you are getting enough fiber and micronutrients.

Uniform dietary interventions fail to deliver consistent metabolic benefits in individuals with metabolic syndrome due to biological heterogeneity, whereas food-based dietary patterns emphasizing whole foods and limiting ultra-processed foods provide relatively consistent metabolic benefits across diverse phenotypes.

Stop looking for a single 'best' diet for metabolic syndrome. Instead, focus on the quality of your food: eat more whole foods (vegetables, fruits, legumes, whole grains) and minimize ultra-processed foods. This approach is more likely to benefit you regardless of your specific metabolic profile.

Adopting a low-carbohydrate, high-fat dietary pattern (defined as carbohydrate energy ≤40-49% and fat energy ≥34-40%) is associated with a significantly lower triglyceride-glucose (TyG) index, a surrogate marker for insulin resistance, primarily through the reduction of fasting triglyceride levels.

To potentially improve your insulin resistance markers, consider shifting your energy intake to include fewer carbohydrates (around 40-49% of calories) and more fat (around 34-40% of calories). This shift is linked to lower triglyceride levels, which is a key component of insulin resistance. Focus on whole food sources for these macronutrients.

Higher consumption of ultra-processed foods (UPF), specifically beverages and snacks, is significantly associated with food addiction (FA) in young adults, independent of BMI and other demographic factors.

If you struggle with compulsive eating or 'food addiction,' focus on reducing ultra-processed beverages and snacks. These specific categories showed the strongest link to addictive behaviors in young adults, regardless of your weight. Prioritize whole foods to potentially reduce the reinforcing power of your diet.

Consuming whole dairy milk provides superior nutrient bioavailability and fewer adverse metabolic effects compared to isolated dairy nutrients or high-dose supplements due to the protective food matrix.

Prioritize drinking plain cow's milk over calcium supplements or isolated whey powders when possible. The natural structure of milk helps your body absorb nutrients better and avoids potential side effects linked to high-dose isolated supplements.

Fermented dairy products offer enhanced health benefits compared to unfermented milk due to bioactive compounds produced during fermentation and reduced lactose content.

If you experience bloating or discomfort from milk, try fermented options like yogurt or kefir. The fermentation process breaks down lactose and creates beneficial compounds that support gut health.

Specific micronutrients (folate, choline, resveratrol, EGCG) can mitigate toxin-induced epigenetic damage by altering DNA methylation and histone modification patterns.

Ensure adequate intake of methyl-donors (folate, choline, B vitamins) and antioxidants (resveratrol, EGCG) to help mitigate the epigenetic damage caused by environmental toxins like smoke and alcohol.

In patients with Type 1 Diabetes (T1D), weight loss interventions reduce insulin requirements but do not significantly improve glycemic control (HbA1c), unlike in Type 2 Diabetes where weight loss directly improves glycemic control.

If you have T1D and are losing weight, do not be discouraged if your HbA1c doesn't drop significantly. The main benefit is that you will likely need less insulin, which reduces your risk of hypoglycemia. Work with your provider to adjust your insulin doses as you lose weight to maintain safety, rather than expecting HbA1c to improve automatically.

Dietary guidelines are a key leverage point for public health progress on obesity and chronic disease because they directly influence consumer behavior and shape federal/state policy and regulations.

Dietary guidelines are not just suggestions; they are the foundation for food labeling, school lunches, and government assistance programs. While they may not single-handedly solve obesity, they are the primary tool available to shift the food environment and consumer habits at a population level.

Obesity is a significant independent predictor of multimorbidity (two or more chronic non-communicable diseases), increasing the likelihood by 1.87 times compared to normal-weight individuals, even after adjusting for socioeconomic and demographic factors.

Maintaining a healthy weight is a critical strategy for preventing the accumulation of multiple chronic diseases, such as hypertension and diabetes. In this population, obesity nearly doubles the risk of having two or more conditions compared to normal weight. Public health interventions should prioritize weight management and access to care for obese individuals to reduce the overall burden of disease.

In older adults with sarcopenia, those with higher baseline functional reserve (Gait Speed ≥ 0.8 m/s or SPPB = 8) experience significant functional decline over 6 months, whereas those with lower baseline function do not show significant change in gait speed.

For older adults with sarcopenia, functional decline is not uniform. Those who still have some mobility reserve (walking speed ≥ 0.8 m/s) are actively losing function and are at higher risk for rapid decline. Those with very low function may appear stable simply because they have reached a functional floor. Monitoring should focus on those with residual capacity who are losing it.

Sarcopenic Obesity (SO) is associated with significant deterioration in functional exercise capacity (6MWD) over 6 months, even when gait speed changes are not statistically significant.

For older adults with both sarcopenia and obesity, functional decline may manifest as reduced walking distance rather than slower walking speed. Regular assessment of walking capacity (like the 6-minute walk test) is important to detect deterioration in this group.

Short-term body mass manipulation (SBM) in powerlifting should be limited to approximately 3% body mass loss when the weigh-in-to-competition window is two hours, as larger losses impair rehydration capacity and performance.

If you must cut weight for a powerlifting meet with a 2-hour weigh-in, do not lose more than 3% of your body weight. Losing more than this amount makes it physically impossible to rehydrate and refuel enough to perform safely and effectively in the short window available. Focus on water loading and sodium manipulation within this 3% limit rather than extreme dehydration.

Gastrointestinal content reduction via low-fiber diets is a safe and effective first-line SBM strategy that can reduce body mass by 0.5-2% without impairing performance.

Start your cut 2-4 days before weigh-in by switching to a low-fiber diet (<10g fiber/day). Eat white rice, bread, eggs, meat, and oils. Avoid nuts, seeds, and high-fiber vegetables. This can safely reduce your body weight by 0.5-2% without affecting your hydration or energy levels.

Longer duration of the coach-lifter relationship is associated with greater increases in powerlifting total (performance).

If you are working with an online powerlifting coach, prioritize building a long-term relationship over finding a 'magic bullet' program. The data suggests that sticking with one coach for a longer period (average >21 months in this study) is more strongly linked to performance gains than how often you talk to them. Trust and consistency matter.

Higher coach education in a field relevant to exercise is associated with greater lifter satisfaction and increased powerlifting total.

When choosing an online coach, look for formal education in exercise science or a related field. This study links higher education to higher lifter satisfaction and better performance outcomes, likely because educated coaches can better explain and justify their programming.

Higher levels of the satiety hormone leptin are associated with lower salt taste preference during both low-carbohydrate and low-fat diets.

Your body's satiety hormone, leptin, appears to influence how much you prefer salty foods. Higher leptin levels are linked to a lower preference for salt, regardless of whether you are eating low-carb or low-fat. This suggests a biological link between fullness signals and taste preferences.

GLP-1 receptor agonists (semaglutide, tirzepatide) cause rapid, significant loss of facial and body subcutaneous fat, leading to skin laxity, volume loss, and accelerated facial aging that requires proactive, multimodal aesthetic intervention.

If you are taking Ozempic or Mounjaro, expect your face to lose volume and your skin to sag. Don't wait until you look 'old' to act. Start aesthetic treatments (like fillers or skin tightening) early in your weight loss journey to maintain your shape and youthfulness.

A structured, multimodal aesthetic intervention protocol (fillers, RF, HIFU, collagen stimulators) initiated early in GLP-1 therapy mitigates facial volume loss and skin laxity.

Work with a cosmetologist to create a personalized plan. Use fillers for volume, RF/HIFU for tightening, and collagen stimulators for skin quality. Start early, not after you've lost all the weight.

Preoperative weight stabilization for 3-6 months is a critical criterion for body contouring surgery to ensure aesthetic results and patient safety.

Do not rush into body contouring surgery immediately after losing weight. Wait until your weight has been stable for at least 3-6 months (often 15-18 months after bariatric surgery) to ensure the best aesthetic result and minimize the risk of needing revision surgery.

GLP-1 receptor agonists (e.g., semaglutide) can support sustained weight stability and may be safely restarted postoperatively in body contouring patients.

If you are using GLP-1 agonists like semaglutide for weight loss, discuss with your doctor whether it is safe to restart or continue them after body contouring surgery. They can help maintain your weight stability and support long-term results.

Combined obesity medicine and metabolic bariatric surgery care produces more optimal outcomes and reduces costs compared to siloed practice.

Seek a clinic that offers both medical weight loss management and surgical options under one roof or coordinated care plan. This ensures you are evaluated for all treatments, not just one.

Patients with prior experience using anti-obesity medication (AOM) demonstrate significantly higher acceptance, interest, and willingness to pay for Traditional Chinese Medicine (TCM) therapies compared to those without such experience.

If you are using or have used prescription weight loss medications (like Semaglutide or Liraglutide), you are statistically more likely to benefit from and accept Traditional Chinese Medicine (acupuncture, dietary advice) than those who haven't. Healthcare providers should proactively offer TCM options to this group, as they are more open to integrative care and willing to pay for it.